|
Nycomed US is the US specialty pharmaceutical business of Switzerland's Nycomed International. It operates through three divisions and is focused on making and selling drugs for dermatological conditions. Its largest division E. Fougera & Co. primarily makes generic topical steroids, antibiotics, and antifungals. It makes both prescription and over the counter products for use in hospitals and sale through independent retailers. Fougera's sister division PharmaDerm develops and markets branded prescription dermatology products. Nycomed US' Savage Laboratories makes prescription emergency medicines including antivenin for snake bites and an antidote for digitalis poisoning.
|
| | | Contact Information | |
Address: |
60 Baylis Rd.
Melville, NY 11747
| | Phone: | 631-454-7677 | | Fax: | 631-454-6389 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 257.00 M | | Employees (2008): | 575 |
|
|
Key People
| | • |
CEO:
Paul McGarty
| | • |
VP, Manufacturing; VP, Operations, Fougera:
Helen Corso
| | • |
CFO, Fougera:
Art Dulik
|
|
|
